Aster CMI Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Liver cirrhosis1 trial
• Lung cancer1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Eli Lilly and Company1 trial
• Noorik Biopharmaceuticals AG1 trial

Running trials

• Not yet recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

  NCT07838155· Phase 4· Eli Lilly and Company· Source

  Contact: Lokesh B (principal investigator)

• Recruiting

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· Phase 2/3· Bristol-Myers Squibb· Source

  Contact: C N Patil, Site 0263

• Active, not recruiting

  Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

  NCT06256432· Phase 2· Noorik Biopharmaceuticals AG· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Lung cancer1 recruiting